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Genetic Regulation of Endothelial
Vasomotor Function
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The endothelium plays an important role in the regulation of vasomotor tone
and the maintenance of vascular integrity. Endothelial dysfunction, i.e., impaired
endothelial dependent dilation, is a fundamental component of the pathogenesis of
cardiovascular disease. Although endothelial dysfunction is associated with a number
of cardiovascular disease risk factors, those risk factors are not the only determinants
of endothelial dysfunction. Despite knowing many molecules involved in endothelial
signaling pathways, the genetic contribution to endothelial function has yet to be
fully elucidated. This mini-review summarizes current evidence supporting the genetic
contribution to endothelial vasomotor function. Findings from population-based studies,
association studies for candidate genes, and unbiased large genomic scale studies in
humans and rodent models are discussed. A brief synopsis of the current studies
addressing the genetic regulation of endothelial responses to exercise training is also
included.
Keywords: flow-mediated dilation, endothelium-dependent vasodilator, heritability, polymorphism, association
studies, rodent strain comparison
INTRODUCTION
The endothelium is an importantmodulator of vascular function, sensing changes in hemodynamic
forces and blood-borne signals, and responding by releasing vasoactive molecules (Hintze and
Vatner, 1984; Pohl et al., 1986; Rubanyi et al., 1986; Sinoway et al., 1989; Koller and Kaley, 1991;
Hecker et al., 1993). Clinically, endothelial dysfunction is characterized by a reduced response
to infusion of endothelium-dependent vasodilators, such as acetylcholine (ACh; Nabel et al.,
1990; Hasdai and Lerman, 1999), or impaired flow-mediated dilation (FMD). FMD measures
vasodilation induced by reactive hyperemia after release of acute occlusion of the brachial artery
(Celermajer et al., 1992). This acute increase in blood flow exerts shear forces on the vessel
that stimulate endothelial cells to release primarily nitric oxide (NO) which subsequently relaxes
vascular smooth muscle (Pohl et al., 1986; Rubanyi et al., 1986). Endothelial dysfunction is a
predictor of future cardiovascular events (Yeboah et al., 2009; Inaba et al., 2010; Ras et al., 2013)
and also contributes to the pathology of chronic diseases including diabetes (McVeigh et al., 1992;
Williams et al., 1996), chronic kidney disease (Annuk et al., 2001; Stam et al., 2006), and Alzheimer’s
disease (Dede et al., 2007; Kelleher and Soiza, 2013).
Chan et al. estimated that known risk factors for coronary heart disease account for <20% of
variation in vascular responses to vasodilator agents (Chan et al., 2001). Differences in resting blood
flow may account for up to another 45%. Therefore, the remaining 30–40% of variation in vascular
function is unexplained. Although one potential factor is genetic variation, genetic regulation
of endothelial vasomotor function is poorly understood. This mini-review will concentrate on
the role of genetic variants on vascular function, emphasizing endothelium-dependent responses.
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We will summarize the results from candidate gene studies
in humans and rodents and highlight genome-wide studies of
genetic regulation of endothelial function.
GENETIC REGULATION OF ENDOTHELIAL
FUNCTION IN HUMANS
Familial Resemblance and Heritability
In children and first-degree relatives of individuals with
premature coronary disease, impaired endothelial function
occurs before onset of overt disease and is significantly and
independently correlated with family history of premature
coronary disease (Clarkson et al., 1997; Gaeta et al., 2000).
Furthermore, twin and family studies suggest endothelial
function or FMD is a heritable trait. A significant familial
aggregation was reported for FMD measured in 81 nuclear
families with a heritability estimate of 0.58 for FMD in
sibling pairs (Ryabikov et al., 2007). The Northern Manhattan
Family Study reported heritability for FMD of 0.17 in Hispanic
Caucasians after adjusting for age, sex, and cardiovascular disease
(CVD) risk factors (Suzuki et al., 2008). Several twin studies
have reported higher resemblance in FMD between monozygotic
twins than dizygotic twins with heritability estimates between
0.24 and 0.44 (Jartti et al., 2002; Zhao et al., 2007; Hopkins et al.,
2010). Two population-based studies estimated heritability for
FMD to be 0.14–0.16 after accounting for confounding variables
(Benjamin et al., 2004; Fisch et al., 2015). Collectively those
findings support a role for genetics in development of endothelial
dysfunction and heritability of endothelial function measured as
FMD.
Candidate Gene Studies
To date, the majority of research focusing on the genetic basis
for endothelial vasomotor function has used the candidate
gene approach. Association studies in humans have shown
polymorphisms in genes related to vascular function [e.g.,
angiotensin converting enzyme, angiotensin II type 1 receptor,
cytochrome b-245 alpha chain (CYBA), nitric oxide synthase 3
(NOS3), and GTP cyclohydrolase 1 (GCH1)] exhibit a range of
effects on endothelial function (Table 1; Celermajer et al., 1994;
Schächinger et al., 2001; Rossi et al., 2003; Schneider et al., 2003;
Cattaruzza et al., 2004; Fricker et al., 2004; Paradossi et al.,
2004; Demirel et al., 2005; Fan et al., 2007; Kiliszek et al., 2007;
Antoniades et al., 2008; Ingelsson et al., 2008; Liao et al., 2010;
Akpinar et al., 2014; Dong et al., 2014; Rafiq et al., 2014; Wolkow
et al., 2014; Li et al., 2015). Two polymorphisms in NOS3,
T−786→C and G894 →T, are the most studied. T−786→C resides
in the promoter region of NOS3 and regulates transcriptional
initiation (Nakayama et al., 1999). The CC genotype at T−786→C
is associated with blunted forearm blood flow responses to
ACh in hypertensive subjects (Rossi et al., 2003) and no
increases in NOS3 mRNA and endothelial nitric oxide synthase
(eNOS) protein expression in response to laminar shear stress in
endothelial cells from coronary heart patients (Cattaruzza et al.,
2004). The G894 →T polymorphism in exon 7 of NOS3 results
in substitution of glutamate with aspartate at codon 298 (also
denoted as Glu298Asp;Marsden et al., 1993). This polymorphism
was significantly associated with FMD; TT genotype carriers
had higher FMD than GG or GT genotype carriers (Ingelsson
et al., 2008). However, these results are not consistent in the
literature (Paradossi et al., 2004; Ingelsson et al., 2008). Moreover,
in a cohort of 1446 subjects from the Framingham Heart Study,
no significant associations were observed between FMD and
18 single nucleotide polymorphisms (SNPs) in NOS3, including
T−786→C and Glu298Asp (Kathiresan et al., 2005). Thus, the
effects of NOS3 polymorphisms on endothelial function are
variable and might depend on the study population or other
genetic or environmental factors.
Polymorphisms in genes regulating NO bioavailability also
have been tested for associations with endothelial function.
One is the C242→T polymorphism located in exon 4 of the
p22phox subunit of NADPH oxidase (CYBA), which decreases
O−2 production. In >2000 subjects, Fan and colleagues found
that T allele carriers showed higher brachial FMD (%) than C
allele carriers (Fan et al., 2007). Schächinger also reported T
allele carriers had greater endothelium-dependent vasodilator
responses in epicardial arteries as compared to C allele carriers
(Schächinger et al., 2001). However, the polymorphic effect of
C242→T on endothelial function is not consistently observed in
smaller studies (Schneider et al., 2003; Fricker et al., 2004; Kiliszek
et al., 2007; Rafiq et al., 2014). In contrast, polymorphisms
in GTP cyclohydrolase 1 (GCH1), the rate-limiting enzyme
in the synthesis of eNOS cofactor 6R-tetrahydrobiopterin
(BH4), significantly affect endothelium-dependent vasodilation
(Antoniades et al., 2008; Liao et al., 2010; Wolkow et al., 2014).
Thus, variation in genes affecting NO bioavailability might
have clinical implications for treating endothelial dysfunction.
However, consistent association of any polymorphism with
endothelial function is not yet firmly established.
In addition to genes affecting NO bioavailability and
responsiveness, polymorphisms in other vascular biology
related genes also are potential modifiers of endothelial
vasomotor function. An apolipoprotein A-I mutation (L178P)
was associated with impaired FMD and enhanced CVD
risk (Hovingh et al., 2004). Similarly, FMD was lower in
diabetic patients without angiopathy carrying the e4 allele
of apolipoprotein E (APOE, ApoE4) (Guangda and Yuhua,
2003; Guangda et al., 2006). The recent finding that the R952Q
variant in apolipoprotein E receptor 2 (ApoER2) and ApoE4
negatively affect NO-mediated endothelial cell repair and
eNOS activation substantiated the link between ApoE4 and
impaired endothelial function (Ulrich et al., 2014). Furthermore,
polymorphisms in paraoxonase 1 (PON1), an antioxidant
linked to high-density lipoproteins, have been associated with
endothelial dysfunction. Male diabetics with the arginine allele
of the Gln192Arg polymorphism in PON1 had reduced FMD
compared with male homozygotes for the glutamine allele (Irace
et al., 2008). Conversely, variation in PON1 was associated
with coronary endothelial dysfunction in women, but not men
(Yoshino et al., 2016). Those results suggest that sex, vessel
size, and disease status might influence the variant effects
of PON1. Further investigation into the role of this gene on
endothelial function is warranted. Collectively, these associations
suggest genetic regulation of endothelial vasomotor function
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involves pathways not directly associated with the canonical NO
pathway.
Genome Wide Association Studies
Over the last decade, genome-wide association studies (GWAS)
have been used to identify novel genetic loci underlying CVD
and other chronic diseases, but GWAS for endothelial function
have been limited. Vasan and colleagues conducted an association
study for several cardiovascular traits including FMD (%) and
hyperemic flow velocity in 1345 subjects from the Framingham
Heart Study using a 100k SNP set (Vasan et al., 2007). They
identified several SNPs associated with each trait, including SNPs
in cystic fibrosis transmembrane conductance regulator (CFTR)
and phosphodiesterase 5A (PDE5A).CFTR encodes for a chloride
ion channel expressed in endothelial and vascular smooth muscle
cells (Tousson et al., 1998; Robert et al., 2005). PDE5A encodes a
cGMP-specific phosphodiesterase that regulates smooth muscle
relaxation (Kass et al., 2007). Although those findings have not
been replicated, that was the first GWAS to directly investigate
endothelial function in a large size sample population, offering a
fundamental framework for GWAS of endothelial function.
Subsequently, Yoshino and colleagues performed an
association study for coronary vascular responses to ACh, an
index of coronary endothelial function, in 643 female and male
subjects (Yoshino et al., 2016). They utilized 1536 tag SNPs
located in genes previously connected with cardiovascular
physiology and pathology. Variants in adenosine A1 receptor
(ADORA1) were associated with endothelial dysfunction in the
entire cohort, whereas variants in adenosine A3 receptor
(ADORA3) and lipoprotein(a) (LPA) had the strongest
associations with increased risk of endothelial dysfunction
in women only. Their sex-specific results further suggest
genetic regulation of endothelial (dys)function might differ
between sexes and future studies must consider sex by genotype
interactions.
Genetic Contribution to Endothelial
Responses to Exercise Training
Exercise training is a non-pharmacological means to improve
endothelial function. However, there is growing acceptance that
phenotypic responses to exercise training are heterogeneous.
Green observed a wide range of inter-individual variation in
FMD (%) changes after exercise training (Green et al., 2014).
Among 182 subjects, 76% exhibited improved FMD, while
24% showed no changes or even decreased FMD after exercise
training. Thus, exercise training can exert non-uniform effects
on endothelial function among individuals. Hopkins (Hopkins
et al., 2012) provided evidence for a genetic contribution to these
variable responses. After 8 weeks of aerobic exercise training
changes in FMD (%) were highly correlated inmonozygotic twins
(r = 0.63), whereas changes in FMD (%) were not correlated
in dizygotic twins (r = 0.37). The estimated heritability of
training-induced changes in FMDwas 0.74, which is significantly
higher than estimates of heritability for FMD in non-exercise
training studies. Whether genetic influence on endothelial
responses to exercise training is also significantly greater remains
to be determined.
Because improvements in endothelial function with exercise
training can occur primarily through changes in NO signaling,
the impact of polymorphisms in NOS3 and related genes on
endothelial responses to exercise training has been examined.
In coronary artery disease patients, exercise training for 4
weeks improved ACh-induced average peak velocity (APV)
in coronary arteries relative to NOS3 polymorphism (Erbs
et al., 2003). Patients carrying C allele at T−786→C had a
smaller improvement in APV (∼36%) than patients carrying
T allele (∼ 81%), whereas a polymorphic effect of G894 →T
was not observed. Similarly, 18 weeks of exercise training
increased forearm vascular conductance during handgrip
exercise in TT carriers, but not in CT or CC carriers at
T−786→C of NOS3 (Negrao et al., 2010). For other vascular-
related genes, there is limited information regarding their
role in improved endothelial function with exercise training
(Park et al., 2007; Alves et al., 2013; Lemos et al., 2016).
The mixed results from those and other association studies
imply there is a complicated interaction between genetic
factors and exercise on endothelial adaptation to exercise
training.
GENETIC REGULATION OF ENDOTHELIAL
FUNCTION IN RODENTS
Candidate Gene Studies
Candidate gene studies in rodents also have focused on genes
previously linked to endothelial physiology and pathology.
Many of these genes have been reviewed elsewhere (Faraci
and Sigmund, 1999), and full discussion is beyond the scope
of this review. Typically those studies have been conducted
using knockout mouse models to test a direct functional role
of a gene in a vascular phenotype or investigate associated-
signaling pathways (Babinet, 2000; Hall et al., 2001). They
also have been useful in identifying differences in endothelial
function throughout the vascular tree (Gongora et al., 2006),
but the clinical relevance of complete gene knockout or
overexpression is unclear. Recently, mouse models mimicking
subtle genetic variation seen in humans have been developed.
A single point mutation at the S1176 phosphorylation site
on eNOS that increased enzyme activity also improved
endothelial function and clinical outcomes in mice (Atochin
et al., 2007; Li et al., 2013). Conversely, responses to ACh
are attenuated in blood vessels from mice carrying cell
specific dominant-negative versions of PPARγ that mimic
human mutations in this gene, but only after high fat diet
or angiotensin II infusion (Beyer et al., 2008; Hu et al.,
2016). Thus, in mice, genetic modifications resembling human
polymorphisms or mutations provide proof of concept that
small genetic changes can elicit relevant (patho)physiological
changes in endothelial vasomotor function without eliciting
marked systemic changes or deleterious effects due to complete
gene loss or overexpression. These models can facilitate more
precise mechanistic investigation of vascular function, but
also provide information that is more translatable to human
pathophysiology.
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Mouse and Rat Strain Comparisons
An alternative approach for investigating the genetic basis for
vascular function is an inter-strain comparison of vascular
phenotypes among different inbred rodent strains. Phenotypic
diversity across inbred strains permits identification of novel
gene(s) responsible for a phenotype via association analysis
between phenotype and genotype over the entire genome
(Flaherty et al., 2005; Flint and Eskin, 2012). Although no large-
scale (≥10) rodent strain surveys for vascular function have
been published, several small studies indicate strain-dependent
differences in endothelium-dependent vasorelaxation (Table 2;
Bendall et al., 2002; Ryan et al., 2002; Chen et al., 2007). Each
study reported impaired responses to ACh in isolated aorta
from at least one mouse strain. However, responses to other
endothelium-dependent agonists were not consistent, nor were
responses in vessels from other vascular beds. Ryan found that
two 129-substrains of mice had markedly reduced responses to
ACh in isolated aorta, but not carotid arteries, compared with
5 other inbred mouse strains (Ryan et al., 2002). Alternatively,
outbredMF1mice showed impaired responses to ACh in isolated
aorta and reduced coronary relaxation responses to bradykinin
and ACh in isolated perfused hearts (Bendall et al., 2002). Thus,
genetic background influences endothelial function in mice;
however, the magnitude might vary depending on the vascular
bed. In addition, parallel to lower responses to ACh in aorta
from SJL mice, eNOS, and SOD-2 protein expression were lower
(Chen et al., 2007). Similarly, impaired responses to ACh in
aorta from outbred MF1 mice improved after incubation with
the superoxide scavenger Tiron (Bendall et al., 2002). Together
these findings imply decreased NO bioavailability may contribute
to impaired vasorelaxation responses. However, mechanisms
underlying variation in eNOS and antioxidant signaling pathway
protein content among inbred mouse strains remain to be
elucidated.
Supportive evidence also has been derived from investigations
in genetically manipulated rats. A consomic rat panel was created
by substituting chromosomes from normotensive BrownNorway
(BN) rats onto the background of the Dahl salt sensitive (SS)
inbred rat strain (Cowley, 2003). Phenotype comparisons across
consomic and inbred parental SS strains afford opportunity
to discover chromosomes containing genes contributing to the
phenotype of interest. Using that rat consomic panel, aortic
rings from strains with substituted chromosomes 16 and Y
had greater ACh sensitivity, while aortic rings from strains
carrying chromosomes 9, 13, and 20 had reduced sensitivity
compared with aorta from inbred parental SS rats (Kunert et al.,
2006). These results indicate that chromosomes 9, 13, 16, 20,
and Y contain gene(s) responsible for ACh sensitivity. These
investigators later utilized a consomic rat panel constructed
from BN and Fawn Hooded Hypertensive (FHH) rat strains
(Kunert et al., 2010). ACh sensitivity differed for consomic
rats of chromosomes 3, 4, 5, 10, 11, 12, 14, and Y compared
to parental FHH inbred rats. Only the Y chromosome was
identified in both studies as influencing ACh sensitivity, implying
chromosomes responsible for endothelial sensitivity to ACh are
strain-specific in rats (Kunert et al., 2006, 2010). Collectively,
results from animal studies clearly indicate endothelial function
has genetic regulation and support comprehensive genomic
scans via objective and unbiased hypothesis-free tests to
identify novel genomic loci responsible for regulating endothelial
function.
FUTURE DIRECTIONS
The endothelium has a critical role in maintaining vascular
integrity and protecting against cardiovascular disease.
Accumulated data indicate endothelial function is a heritable
trait regulated by polygenic factors; however, these genetic
factors have not been fully elucidated. Given that single genetic
variants generally have only small to modest functional effects,
future studies should focus on endothelial function in larger
populations (humans or rodents) to facilitate genome wide
studies and comprehensively unravel the complex genetic basis
of endothelial function. In addition, the majority of studies cited
here utilized FMD, a measure of endothelial function in a conduit
artery. However, many cardiovascular diseases are associated
with endothelial dysfunction in resistance vessels. Collectively,
there is less evidence regarding genetic regulation of endothelial
function in small vessels and FMD measurements do not always
agree with assessment of resistance artery endothelial function
via infusion of ACh (Lind et al., 2011). Therefore, studies directly
assessing endothelial function in resistance arteries are needed
to better understand the genetic regulation of resistance artery
endothelial function and its contribution to cardiovascular
disease progression.
Because many GWAS identify SNPs outside protein coding
regions or in non-coding intervals, the contribution of small
non-coding RNA (e.g., lncRNA, microRNA) in modulating
endothelial function should be addressed. Emerging evidence
suggests microRNA levels are associated with impaired responses
to ACh in humans (Widmer et al., 2014) and rodents (Norata
et al., 2012; Li et al., 2016). Heritable changes in gene activity and
expression also can be the result of epigenetic changes. Recent
evidence suggests epigenetic changes such as those induced by
histone methyltransferase Set7 are associated with endothelial
dysfunction, including impaired FMD in diabetics (Paneni
et al., 2015). Furthermore, responses to ACh were impaired in
aortic segments from heterozygous lysine-specific demethylase-
1 (LSD-1) mice (Pojoga et al., 2011). A polymorphism in
LSD-1, which induces histone H3 demethylation, is associated
with salt-sensitive hypertension in humans (Williams et al.,
2012). Therefore, expanding the search for genetic regulators of
endothelial vasomotor tone beyond candidate gene studies could
facilitate discovery of modulators of endothelial function and
cardiovascular disease.
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